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ABSTRACT
Objectives: To project the number of older workers
with lost productive life years (PLYs) due to chronic
disease and resultant lost income; and lost taxes and
increased welfare payments from 2015 to 2030.
Design, setting and participants: Using a
microsimulation model, Health&WealthMOD2030, the
costs of chronic disease in Australians aged 45–64
were projected to 2030. The model integrates
household survey data from the Australian Bureau of
Statistics Surveys of Disability, Ageing and Carers
(SDACs) 2003 and 2009, output from long-standing
microsimulation models (STINMOD (Static Incomes
Model) and APPSIM (Australian Population and Policy
Simulation Model)) used by various government
departments, population and labour force growth data
from Treasury, and disease trends data from the
Australian Burden of Disease and Injury Study (2003).
Respondents aged 45–64 years in the SDACs 2003 and
2009 formed the base population.
Main outcome measures: Lost PLYs due to chronic
disease; resultant lost income, lost taxes and increased
welfare payments in 2015, 2020, 2025 and 2030.
Results: We projected 380 000 (6.4%) people aged
45–64 years with lost PLYs in 2015, increasing to
462 000 (6.5%) in 2030—a 22% increase in absolute
numbers. Those with lost PLYs experience the largest
reduction in income than any other group in each year
compared to those employed full time without a
chronic disease, and this income gap widens over
time. The total economic loss due to lost PLYs
consisted of lost income modelled at $A12.6 billion in
2015, increasing to $A20.5 billion in 2030—a 62.7%
increase. Additional costs to the government consisted
of increased welfare payments at $A6.2 billion in 2015,
increasing to $A7.3 billion in 2030—a 17.7% increase;
and a loss of $A3.1 billion in taxes in 2015, increasing
to $A4.7 billion in 2030—a growth of 51.6%.
Conclusions: There is a need for greater investment
in effective preventive health interventions which
improve workers’ health and work capacity.
INTRODUCTION
A substantial increase in years lived with dis-
ability (YLDs) globally has occurred in the
past 20 years. Global Burden of Disease
Collaborators (2015) estimated YLDs for 301
acute and chronic diseases and injuries and
2337 sequelae using DisMod-MR and
reported 537.6 million YLDs from all causes
globally in 1990, increasing to 764.8 million
in 2013 due to population growth and
ageing.1 Although this study provides essen-
tial information about current and expected
Strengths and limitations of this study
▪ The first Australian study to project the economic
costs of older workers exiting the labour market
due to chronic disease from the perspective of
individuals, government and the nation over a
long-time horizon (ie, out to 2030).
▪ The study uses a microsimulation model on the
impacts of ill health, Health&WealthMOD2030,
which integrates output from two long-standing
income, tax and welfare payments microsimula-
tion models (Static Incomes Model and Australian
Population and Policy Simulation Model) and reli-
able labour force and disease trends data.
▪ Study findings are based on Surveys of
Disability, Ageing and Carer respondents’ self-
reported labour force status and chronic disease.
▪ This study provides novel insights into the inter-
dependency of chronic disease, labour force par-
ticipation and economic outcomes, with potential
implications for clinical care, health policy (and
setting priorities) by supporting preventive health
interventions which improve the health outcomes
and capacity to work of people with chronic
disease and subsequently have an impact on
longer term costs (such as personal incomes,
welfare payments, tax paid).
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YLDs for chronic diseases, governments are concerned
about the impact of chronic disease on the capacity of
citizens to remain in the labour force, that is, productive
life years (PLYs) lost due to chronic disease, which we
define as the loss of productivity because of individuals
not being able to participate in the labour force due to
their chronic conditions. This is computed as the
number of individuals not in the labour force because
of their ill health at particular time points. These are
the individuals who would be in the labour force if they
did not have a chronic condition.2
The significant economic costs of chronic disease have
been emphasised for OECD members.3 4 For example,
25% of men and 21% of women aged 45 years and over
reported ceasing full-time employment because of ‘their
own sickness, injury or disability’ in Australia in 2012–
2013.5 Moreover, 8.5% of people aged 19–44 years
reported being out of the labour force due to ill health,
whereas 22.2% of people aged 45–64 years reported being
out due to ill health, thus supporting the focus of this
paper on examining the impact of chronic disease on pre-
mature retirement. Most OECD countries have an ageing
population, generating a number of challenges. An
increase in the number of people living with chronic
disease (related to ageing) places greater pressure on
health systems, may add to labour shortages and increase
government spending on vital services such as welfare.
Cooke6 reviews the policies used to encourage the labour
force participation of older workers in the six OECD coun-
tries in the Workforce Aging in the New Economy (WANE)
project. The Australian Government’s priority of ‘healthy
ageing’ is designed to encourage older people to contrib-
ute longer to the economy and, for this reason, it has
implemented polices to promote deferred retirement.7
Most estimates of the economic costs of chronic
disease are limited to a single condition. For example,
the national cost of arthritis has been estimated for New
Zealand,8 and mental illness for patients in Australia.9
However, these studies do not consider lost income,
taxes and increased welfare spending as costs for govern-
ments. Even reports by the WHO and OECD, focusing
on a larger number of countries, have only estimated
the impact of three to five diseases (cardiovascular
disease, cancer, diabetes and stroke, heart disease,
chronic lung disease, depression) for either individuals
who exit from paid work due to chronic disease (nega-
tive health effects) or costs measured at the national
level (lost income, lost GDP).10 11 We have previously
examined the economic costs of chronic disease gener-
ally,2 and the top conditions taking older workers out of
the labour force (such as back pain12). However, these
studies have only considered a single year (2009) for esti-
mating costs. The current study aims to project lost PLYs
due to chronic disease and resultant lost income for
individuals, and lost taxes and increased welfare pay-
ments for government from 2015 to 2030. This places
the study among research projecting the economic costs
of chronic disease a decade or more from now, but also
makes an original contribution by measuring these costs
from different perspectives (including budget impacts)
METHODS
Data
We analysed the output data sets from a microsimulation
model Health&WealthMOD2030—Australia’s first micro-
simulation model of the impacts of health and disability
in people aged 45–64 years covering 20 years.
The base population of Health&WealthMOD2030 was
assembled from unit-record data from the Australian
Bureau of Statistics’ (ABS) cross-sectional Surveys of
Disability, Ageing and Carers (SDAC) 2003 and 2009.13 14
From the combined data, the records of people aged 45–
64 years and others in their family were extracted. For
each individual in the base population, there are demo-
graphic (age, sex, family type), socioeconomic (educa-
tion, income, income or other support payments), labour
force (labour force participation, employment restric-
tions, retirement) and health variables (chronic condi-
tions). The development of Health&WealthMOD2030 is
described in detail in Schofield et al.15 The main compo-
nents of Health&WealthMOD2030 and how they are
linked are illustrated in figure 1.
Using a static microsimulation model, STINMOD
(Static Incomes Model),16 additional economic informa-
tion was imputed onto the base population (including
income, welfare payments, taxes paid). STINMOD is the
National Centre for Social and Economic Modelling’s
(NATSEM, University of Canberra) (http://www.natsem.
canberra.edu.au) microsimulation model of Australia’s
income tax and transfer system. Typically, the model is
used to assess distributional and individual impacts of
income tax and welfare policies, and estimate impacts
on the government’s budget and distributional impacts
of policy reform for families.
Using a dynamic microsimulation model, Australian
Population and Policy Simulation Model (APPSIM),17 add-
itional sociodemographic information was imputed onto
the base population (age and sex profile in 2015, 2020,
2025, 2030). APPSIM was developed by NATSEM in col-
laboration with 12 Australian Government departments,
and simulates an annual snapshot of the Australian
population from 2001 to 2051. Snapshots from 2015 to
2030 are used in this study.
The output data sets from Health&WealthMOD2030
are the projected representation of the Australian popu-
lation in 2015, 2020, 2025 and 2030. Demographic,
socioeconomic, disease prevalence changes in the
Australian population between the base years (ie, survey
years 2003, 2009) and the projection years (ie, 2015,
2020, 2025, 2030) were captured through static ageing
techniques. Both SDAC 2003 and 2009 data sets had
survey weights assigned to each record by the ABS to
account for unequal probability of individual selection
in the surveys, and to make the survey data a true repre-
sentation of the Australian population in the survey
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years. These weights reflect the number of people with
similar characteristics in the Australian population in the
year of surveys (2003 and 2009). SDAC 2003 and 2009
were separately reweighted using the ABS reweighting
algorithm Generalised Regression Weighting Tool
(GREGWT) to account for demographic, socio-
economic, disease prevalence changes in the population
between the survey years (2003, 2009) and projection
years (2015, 2020, 2025, 2030). GREGWT uses the gener-
alised regression method to modify the initial survey
weights (ie, 2003 and 2009 weights) such that the data
sets with new weights become the representation of the
Australian population for the projection years. The
Commonwealth Treasury’s 2013–2014 demographic and
labour force projections were used to account for demo-
graphic and labour force changes over time. Chronic
disease trends from the Australian burden of disease
and injury study were used to account for changes in
disease prevalence over time.18
To account for chronic condition trends, we applied
the same trends in chronic condition incidence used in
the 2003 Australian Burden of Disease and Injury
Study.18 This study applied chronic disease trends from
2003 until 2023, after which time rates were assumed to
stabilise. We calculated age–sex-specific proportional
changes in chronic condition prevalence and applied
these to corresponding diseases in SDAC data, aggre-
gated into the following categories: stroke, cancer
(almost stable in men and women), ischaemic heart
disease (decreasing trend in men and women), type 2
diabetes (increasing trend in men and women) and
chronic obstructive pulmonary disease (stable trend in
men; increasing trend in women). In the absence of
data on trends, the rates for all other conditions were
assumed to remain stable. Based on proportional
changes, the prevalence of chronic conditions among
Australians aged 45–64 years was projected for 2015 and
2030 by 5-year age group and sex.
Economic data from STINMOD for 2013 were
imputed onto Health&WealthMOD2030 using synthetic
matching.19 The matching process was described in
detail in Schofield et al.15 Briefly, unit records of the
STINMOD output for 2013 and the unit records of the
Health&WealthMOD2030 base population were
matched on a set of matching variables common to both
data sets and significantly related to income and the
combined data set with variables from both STINMOD
and Health&WealthMOD2003 was synthetically created.
Ten matching variables were used for synthetic match-
ing. They were labour force status, income unit type,
income quintile, receipt of aged pension, receipt of dis-
ability support pensions, sex, age group, hours of work
per week, education and home ownership.
Finally, economic data from STINMOD 2013 were
indexed to reflect economic growth projections from
2013 to 2030. Income and taxes paid by individuals were
assumed to grow at a rate of 1% per annum (in real
terms).20 Welfare payments were assumed to have no
real growth based on the government’s policy of increas-
ing welfare payments (except for aged pension) in line
with the national Consumer Price Index (CPI) growth.21
The use of ABS SDAC 2003, 2009 data was approved
by the ABS Microdata Review Panel.
Lost PLYs due to chronic disease
In the SDACs, respondents were asked to nominate their
current labour force status as one of the following states:
1. Employed working full time
2. Employed working part-time
3. Unemployed looking for full-time work
4. Unemployed looking for part-time work
5. Not in the labour force
Figure 1 Schematic diagram of Health&WealthMOD2030. ABS, Australian Bureau of Statistics; STINMOD, Static Incomes
Model.
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Respondents who reported that they were not in the
labour force were also asked to provide the main reason
for not working or not looking for work. One of these
options was ‘own ill-health or disability’. All respondents
were asked whether they had a long-term condition, and
to nominate the type of condition they have from a list of
80 diseases. Those identified as (1) being out of the
labour force due to their own ill health or disability and
who (2) reported having a chronic condition were consid-
ered to have lost PLYs due to chronic disease in this study.
Economic measures
In this study, individual income refers to labour market
earnings, income from other sources generating a
return (such as rental properties, investments, interest
on cash in bank) and welfare payments. Welfare pay-
ments in STINMOD relevant for older Australians
include: aged pension, disability support pension,
Newstart Allowance (for people looking for work),
Carer Payment and Family Tax Benefit (http://www.
humanservices.gov.au/customer/services).
Australian pensions are means tested payments not
related to income earned prior to retirement. Thus,
people with greater savings receive a smaller pension;
for example, couples with assets (excluding their home)
receive a reduced pension of $A440 500, and those with
assets exceeding $A1.17 million receive no pension
(https://http://www.humanservices.gov.au/).
Taxes paid refer to income taxes paid (including
Medicare levy) by individuals in a given timeframe
(week, year).
Statistical analysis
Descriptive analysis was undertaken of associations
between chronic disease and projected lost PLYs,
income, taxes and welfare payments in 2015, 2020, 2025
and 2030. We present the mean (SD) and median
weekly income, taxes paid and welfare payments of
people aged 45–64 years out of the labour force because
of ill health (lost PLYs) or in the labour force (employed
full time with and without chronic disease, employed
part-time with and without chronic disease). All figures
are expressed in real 2013 Australian dollars.
A quantile regression model (adjusted for age, sex
and highest level of education) of weekly income was
used to estimate differences between the median weekly
total income of people in employment and those with
lost PLYs. This analysis was repeated for weekly taxes
paid and welfare payments received.
The national impacts of lost PLYs due to chronic
disease were estimated for 2015, 2020, 2025 and 2030
based on the assumption that if those not in the labour
force because of ill health did not have the disease, all
would be in the labour force, while some would work
full time and some would work part-time. The probabil-
ities of working full time and part-time were based on
the estimated probabilities of working full time and part-
time of those who did not have the disease and were in
the labour force. The national impacts were estimated as
the monetary value (cost in real 2013 Australian dollars)
of the aggregate of lost income, extra welfare payments
and lost taxation revenue due to lost PLYs in each year.
A total of 95% CIs were generated for each outcome
using bootstrapping with 1000 replications for each year.
All analyses were undertaken using SAS V.9.4 (SAS
Institute, Cary, North Carolina, USA). All statistical tests
were two sided with a significance level of 5%.
RESULTS
Among the 19 277 people aged 45–64 years with informa-
tion on their labour force status in the combined SDACs,
6606 were employed full time with no chronic disease;
6076 were employed full time with a chronic disease; 2373
were employed part-time with no chronic disease; 2812
were employed part-time with a chronic disease; and 1410
were not in the labour force due to chronic disease, that
is, lost PLYs in 2015. Once weighted, these data represent
an Australian population aged 45–64 years of 4 817 000
people in 2015. Of these, 1 651 000 (27.8%) were
employed full time with no chronic disease; 1 568 000
(26.4%) were employed full time with chronic disease;
525 000 (8.8%) were employed part-time with no chronic
disease; 693 000 (11.7%) were employed part-time with
chronic disease; and 380 000 (6.4%) had lost PLYs due
to chronic condition in the Australian population aged
45–64 years in 2015. The remaining 19% correspond to
people aged 45–64 years who are unemployed or not in
the labour force due to reasons other than ill health
(table 1).
People not in the labour force due to chronic disease
received $A391.61 in median weekly income and
$A321.87 in median weekly welfare payments (median
income taxes paid was effectively $A0 by definition of
PLYs) in 2015 (table 1). People in this group obtained a
significantly higher amount of welfare income per week
than those employed full time or part-time, and the
median weekly income taxes paid were significantly
lower than that paid by people employed full time or
part-time (table 1).
By 2030, the number of people aged 45–64 years was
projected to be 6 017 000, with 2 019 000 (28.3%)
employed full time with no chronic disease; 1 960 000
(27.5%) employed full time with chronic disease;
677 000 (9.5%) employed part-time with no chronic
disease; 899 000 (12.6%) employed part-time with
chronic disease; and 462 000 (6.5%) who had lost PLYs
due to chronic disease in the Australian population
aged 45–64 years. Trends in labour status including not
in the labour force because of ill health by age group
over the period of 15 years from 2015 to 2030 is shown
in table 2. People with lost PLYs due to chronic disease
in 2030 were projected to receive $A393.15 a week in
median income, $A311.67 a week in median welfare pay-
ments and pay effectively $A0 in income taxes in 2030,
expressed in real 2013 dollars (table 1).
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Table 1 Average and median weekly total income, government welfare payments and taxes paid by individuals by labour force status for the Australian population aged 45–64 years (in 2013 $A) (crude estimates)
2015 2020 2025 2030
Labour force status
Number of
survey
records
Weighted
population
(%) Mean SD Median
Weighted
population Mean SD Median
Weighted
population Mean SD Median
Weighted
population Mean SD Median
Weekly total income ($A) of individuals
Employed full time with no
chronic condition
6606 1 651 000
(27.77)
1626.93 1443.74 1344.76 1 784 000
(27.98)
1757.07 1554.70 1458.75 1 867 000
(27.96)
1901.26 1693.29 1567.26 2 019 000
(28.31)
2039.13 1832.26 1653.38
Employed full time with a
chronic condition
6076 1 568 000
(26.37)
1520.90 1600.42 1255.03 1 725 000
(27.06)
1636.20 1716.33 1351.01 1 827 000
(27.36)
1782.21 1873.76 1443.73 1 960 000
(27.49)
1916.72 2005.36 1529.27
Employed part-time with no
chronic condition
2373 525 000
(8.84)
739.92 813.51 626.28 583 000
(9.15)
792.30 881.92 666.83 621 000
(9.30)
865.00 923.33 725.60 677 000
(9.50)
931.39 948.32 783.39
Employed part-time with a
chronic condition
2812 693 000
(11.65)
675.10 721.82 569.32 780 000
(12.24)
723.32 769.64 601.25 836 000
(12.52)
811.33 811.94 680.44 899 000
(12.61)
892.99 847.83 741.10
Not in labour force due to
chronic condition
1410 380 000
(6.39)
337.23 222.95 391.61 415 000
(6.51)
343.36 246.50 393.15 437 000
(6.54)
349.87 274.40 393.15 462 000
(6.47)
357.45 297.91 393.15
Weekly welfare income ($A) received by individuals
Employed full time with no
chronic condition
6606 1 651 000
(27.77)
19.54 64.44 0.00 1 784 000
(27.98)
18.70 63.04 0.00 1 867 000
(27.96)
16.55 59.24 0.00 2 019 000
(28.31)
15.57 57.80 0.00
Employed full time with a
chronic condition
6076 1 568 000
(26.37)
17.26 61.92 0.00 1 725 000
(27.06)
17.16 62.51 0.00 1 827 000
(27.36)
15.71 60.20 0.00 1 960 000
(27.49)
14.98 58.92 0.00
Employed part-time with no
chronic condition
2373 525 000
(8.84)
64.49 129.45 0.00 583 000
(9.15)
63.84 129.88 0.00 621 000
(9.30)
59.83 125.96 0.00 677 000
(9.50)
57.47 122.54 0.00
Employed part-time with a
chronic condition
2812 693 000
(11.65)
87.37 154.05 0.00 780 000
(12.24)
86.11 154.05 0.00 836 000
(12.52)
78.01 147.33 0.00 899 000
(12.61)
72.92 142.32 0.00
Not in labour force due to
chronic condition
1410 380 000
(6.39)
295.02 172.98 321.87 415 000
(6.51)
293.74 173.97 315.95 437 000
(6.54)
289.36 176.73 311.67 462 000
(6.47)
287.28 178.56 311.67
Weekly tax paid (includes Medicare levy) ($A) by individuals
Employed full time with no
chronic condition
6606 1 651 000
(27.77)
364.23 475.20 253.49 1 784 000
(27.98)
398.29 516.12 281.34 1 867 000
(27.96)
434.57 560.89 302.60 2 019 000
(28.31)
469.49 610.95 320.21
Employed full time with a
chronic condition
6076 1 568 000
(26.37)
327.73 480.01 215.29 1 725 000
(27.06)
356.01 520.54 236.90 1 827 000
(27.36)
390.38 565.75 259.61 1 960 000
(27.49)
422.33 609.79 280.54
Employed part-time with no
chronic condition
2373 525 000
(8.84)
92.94 225.74 26.23 583 000
(9.15)
102.53 244.36 29.07 621 000
(9.30)
111.89 251.43 36.67 677 000
(9.50)
118.82 254.15 45.33
Employed part-time with a
chronic condition
2812 693 000
(11.65)
68.43 164.48 5.42 780 000
(12.24)
76.13 179.30 6.51 836 000
(12.52)
88.79 192.11 21.07 899 000
(12.61)
99.67 204.00 28.78
Not in labour force due to
chronic condition
1410 380 000
(6.39)
2.00 50.11 0.00 415 000
(6.51)
2.72 60.42 0.00 437 000
(6.54)
3.51 71.38 0.00 462 000
(6.47)
4.17 80.06 0.00
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After adjusting for age, sex and education, it was esti-
mated that in 2015, those out of the labour force due to
ill health obtained $A805.32 per week (95% CI
$A769.11 to $A837.17) less in median income than
those employed full time with no chronic disease in
2015 (table 3). Median weekly welfare payments were
significantly higher with this group receiving $A321.88
per week (95% CI $A311.67 to $A344.43) more in
(median) welfare payments than those employed full
time with no chronic disease (with employed people
receiving a median weekly welfare income of $A0)
(table 3). People out of the labour force due to chronic
disease also paid $A203.13 per week (95% CI $A194.01
to $A217.40) less in income taxes than those employed
full time without chronic disease.
Differences in median weekly income, welfare pay-
ments and income taxes between people in the different
labour force/health status groups were estimated for
2030 (table 3, last two columns). Income lost as a result
of being out of the labour force due to chronic disease
increased from $A805.32 per week in 2015 (95% CI
$A769.11 to $A837.17) to $A1057.73 per week in 2030
(95% CI $A1011.64 to $A1091.49) in real terms (com-
pared to those employed full time with no chronic
disease). People with lost PLYs due to chronic disease
paid $A203.13 per week (95% CI $A194.01 to $A217.40)
less in income taxes than those employed full time
without chronic disease in 2015, increasing to $A257.73
per week (95% CI $A242.58 to $A272.45) in 2030.
The national impacts of lost PLYs due to chronic
disease in older workers from 2015 to 2030 are pre-
sented in table 4. Lost annual income was $A12.6 billion
due to lost PLYs in 2015, increasing to $A20.5 billion in
2030 (ie, a 62.7% absolute increase) mainly due to
population growth and ageing. Additional welfare pay-
ments due to lost PLYs were also projected to increase,
from $A6.2 billion in 2015 to $A7.3 billion in 2030 (a
17.7% absolute increase). Finally, lost annual tax
revenue due to lost PLYs was projected to increase in
real terms over time, from $A3.1 billion in 2015 to $A4.7
billion in 2030 (absolute growth of 51.6%).
DISCUSSION
This study projected lost PLYs due to chronic disease in
older workers (aged 45–64 years) and the significant
flow-on effects for individuals (lost income) and govern-
ment (lost taxes, extra welfare payments) from 2015 to
2030—the first set of results of its kind for Australia. We
projected lost personal income due to lost PLYs to
increase from $A12.6 billion in 2015 to $A20.5 billion in
2030 (a 62.70% absolute increase). We also projected
lost taxation revenue due to lost PLYs to increase from
$A3.1 billion in 2015 to $A4.7 billion in 2030 (an abso-
lute increase of 51.6%), which will put greater pressure
on government budgets. Greater reliance on public
healthcare is expected by those who retire early due to
ill health, and increasing costs are likely to occur
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because more people will be eligible for age/disability
pensions in the future.22
According to the WHO, chronic diseases are one of
the foremost health and development challenges facing
countries in the 21st century, through both the human
suffering they cause and the reduced social and eco-
nomic well-being of citizens.23 24 In the absence of
evidence-based actions, the human, social and economic
costs of chronic diseases will continue to grow and over-
whelm the capacity of countries to address them. For
these reasons, local and international research project-
ing the economic costs of chronic diseases is growing.
These studies commonly emphasise the need for better
organisation, adequate funding to improve the availabil-
ity of diagnosis and treatment of chronic diseases, as
well as health promotion and early prevention. Recently,
the authors of a report for the American Heart
Association, Forecasting the future of cardiovascular disease in
the United States,25 projected the direct and indirect costs
associated with a projected 40.5% of the US population
having some form of cardiovascular disease by 2030.
The total direct (healthcare) costs of cardiovascular
disease are projected to triple, from $A273 billion in
2010 to $A818 billion in 2030. Real indirect costs (due
to lost productivity) for all forms of cardiovascular
disease are estimated to increase from $A172 billion in
2010 to $A276 billion in 2030 (a 61% increase). The
report’s authors emphasise that heart and vascular dis-
eases can be effectively prevented, and the main strategy
to combat the epidemic of cardiovascular disease in the
USA should be a reorientation of the health system in
the direction of effective health promotion and preven-
tion. However, few studies have estimated the economic
impacts of chronic diseases specifically for older workers
in OECD and WHO countries. Harbers and
Achterberg10 estimated the burden of five chronic dis-
eases in individuals of pre-retirement and postretirement
age (50 years), the number of people exiting the labour
market because of chronic disease (unemployment,
early retirement), and the health impacts of exiting for
individuals in the OECD in the late 2000s. Abegunde
and Stanciole’s11 approach differs from that in the
OECD report in that they projected the costs of deaths
from three chronic diseases (heart disease, stroke, dia-
betes) measured by lost income and lost GDP (ie,
national, societal costs) from 2005 to 2015.11 This study
makes a further advancement by projecting the costs of
older workers exiting the labour market due to chronic
disease (lost PLYs) for individuals, government and the
nation as a whole using a microsimulation model inte-
grating output from long-standing models and reliable
data. There is a potential application of PLYs lost and
the economic costs associated with it in cost–benefit
models and Disability Adjusted Life Years estimates in
intervention studies.
There is an ongoing debate about how health and
income are related. Weil26 maintains that there are reli-
able reasons for accepting the causality between these
Ta
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two variables to run in both directions. Individuals in
better health are more productive, learn more in formal
educational settings and have more incentives to accrue
human capital because they live longer. Likewise, higher
income for individuals (or countries) improves health in
a range of ways, from improved nutrition to building
public health infrastructure including investment in the
health professionals’ workforce. There is empirical evi-
dence that both of these causal channels are oper-
ational; however, the magnitude of the effects is limited
when applied to cross-sectional differences among indi-
viduals or countries. There is evidence that ‘other
factors’ that concurrently increase income and improve
health outcomes (such as human capital for individuals,
and institutional quality for countries) account for a sig-
nificant amount of the observed correlation between
health and income.26 We have attempted to account for
some of these ‘other factors’ in our models by including
demographic (age, sex) and human capital (education
—highest level of educational achievement) variables.
In Australia, the assertion that increased longevity
automatically translates into longer years in good health
during later working life is not supported by our
research,2 which suggests that despite increases in lon-
gevity there is no improvement in the health status of
the older workers. Furthermore, the Productivity
Commission’s27 report An ageing Australia raised the
prospect of increased longevity without increased years
of healthy life, highlighting credible evidence that over
time there has been an expansion of, rather than a com-
pression in, morbidity in Australia.27 The report also
cited the example of adverse impacts of lifestyle factors
(including growing obesity) on longevity leading to an
increased prevalence of diseases such as diabetes.27
Thus, there are conflicting views about the impact of
income growth and chronic disease prevalence versus
views that the reverse is happening in Australia.
This study has some limitations. Findings are based on
SDAC respondents’ self-reported labour force status and
chronic disease. Although self-reported employment
status and health are regarded as valid measures for
such studies,28 29 there is the potential for bias in results.
Although the SDACs are cross-sectional data, some
survey questions were designed in a way to capture
causal relationships. For example, the SDACs have ‘own
ill-health or disability’ as a category for the main reason
respondents are out of the labour force (causal
relationship).
Although several policies have been implemented to
encourage older workers to remain in the labour force
longer in the OECD,6 those based on financial incentives
may not be sufficient to increase participation because ill
health is commonly the stated reason for exiting. Greater
investment in preventive health interventions that
improve older workers’ health and capacity to work is
needed to maintain labour force participation, economic
growth and to ensure that future governments have suffi-
cient revenue for funding the healthcare of an ageing
population.22 30 The timely management of pain due to
back problems, for example, has been shown to reduce
the detrimental impacts of this condition on individuals,
including labour force participation and related costs
such as reduced wealth.31 Preventative or treatment prac-
tices for back problems shown to be effective in rando-
mised controlled trials (such as physical exercise32 and
continued daily activity33) should continue to be encour-
aged in order to prevent the onset of back problems or
reduce their severity (and resultant pain) in sufferers, as
well as the substantial costs of lost labour force participa-
tion caused by such problems for individuals and the
government.
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